Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

CellProthera has acquired full rights to the transendocardial catheter originally [...]

Full results from the Phase 3 KALOS and LOGOS trials [...]

Almirall has announced plans to initiate a phase 3 clinical [...]

Celon Pharma S.A. has received FDA clearance to advance its [...]

Hansa Biopharma AB has announced positive topline results from the [...]

First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]